As rates of chronic conditions and clinical obstacles continue to rise, it is essential that clinicians seeking to stay at the forefront of modern integrative medicine review the latest topics and education in the field. Included in this year’s comprehensive conference schedule the most current clinical research driving modern Anti-Aging and Integrative Medicine. Preview how well established leaders in the Anti-Aging industry are redefining medicine through the examination of the most clinically relevant topics in integrated health care: the most recent and relevant clinical data.
Longevity: New and Diverse Actionable Information
With scientific discoveries, technological advancements, and improved preventative practices and protocols, life expectancy across the globe has seen a consistent upward trend. It is becoming easier to prevent, treat and cure a range of diseases, thus lowering mortality rates and increasing longevity. Although the U.S. has dropped in global life expectancy rankings due to the ongoing drug crisis and rising suicide rates, the growing aging population of Americans demands advanced breakthroughs in treatment for degenerative illnesses.
Combating degenerative diseases is becoming a subject of increased concern, yet the promise of longevity grows. Early infusion studies of young plasma injections in patients with MS and Parkinson’s Disease showed significant improvements in associated symptoms such as pain and tremors, while its effects on other conditions are still being investigated. Recent research on the neuroprotective potential of nutritional lithium for neurodegenerative illness and cancer will be presented alongside integrative techniques for maintaining gut health. Learn more about the latest research in longevity at Session 1: Longevity 2.0 New and Diverse Actionable Information (Day 1).
Regenerative Medicine and Translational Applications
The rapidly emerging field of stem cell therapy has furthered the burgeoning area of regenerative medicine, with stem cell-based methods demonstrating proven success in reducing amounts of scarred heart tissue post-heart attack, and producing insulin-secreting cells in patients with type 1 diabetes. The development and testing of new drugs using induced pluripotent stem cells is on the rise, with pluripotent stem cells creating cancer cells to test newly formulated anti-cancer drugs. Yet despite a multitude of studies and trials, stem cell therapy remains mostly theoretical, with few treatments reaching even the earliest phases of clinical trials. Future research hopes to revolutionize medical practices with new developments in stem cell technology.
The most recent research reveals the potential of stem cell therapy in the modulation of the immune system, with mesenchymal stem cells (MSCs) able to act locally, producing anti-inflammatory agents and calming inflamed tissue without affecting the whole body. Further evidence has been found, linking MSCs to promising results in neuroregeneration of spinal cord injuries. Explore the latest clinical data in stem cell applications and the rising prevalence of cell-based treatment during Session 2: Paradigm Shifter: Regenerative Medicine and Translational Applications (Day 1).
As state legislatures continue to legalize medicinal marijuana, both healthcare practitioners and patients alike are beginning to embrace cannabis as a potential treatment for an array of chronic diseases and disorders. Cannabis is rapidly becoming an accepted and even preferred form of treatment, most commonly used for chronic pain management. Patients whose symptoms require highly sedative medications such as opiates are progressively reaching for clinical cannabis in hopes of evading unwanted side effects and returning to normal functioning. As clinical cannabis is rapidly becoming accepted as a treatment for an array of chronic diseases and disorders, there is a growing and pressing need for clinical education surrounding medical marijuana.
From chronic pain relief and therapeutic effects on menstruation and menopause to the ability to optimize gut health, cannabinoids are entering the field of integrative medicine with a substantial breadth of new clinical evidence as an alternative treatment option for an array of conditions. Recent research in medicinal cannabis will be presented alongside comprehensive education on the uses of newly-popularized cannabidiol (CBD) in clinical medicine and its function within the body’s endocannabinoid system. Learn more from world-renowned experts in Cannabis Therapeutics, the Knox family of physicians during their lecture The Future of Cannabis in Medicine (Day 2). Explore the current clinical landscape of medical cannabis at Session 3: Medical Cannabis: A Snapshot of the Clinical Landscape (Day 1) and Session 1: Medicinal Cannabis in 2019 – Collaboration and Competence (Day 2).
The concept of Fasting Mimicking Diet (FMD) is considered a nutritional breakthrough: designed to provide the body with natural, nourishing ingredients, while not activating any of the pro-aging processes. Patented by ProLon, FMD is a high-fat, low-calorie intermittent fasting diet designed to promote fat loss, reduce blood sugar, and significantly increase longevity. Studies have proven that fasting for just two to five days a month can reduce biomarkers for diabetes, cancer, and cardiovascular disease as well as improving symptoms in patients with autoimmune disease. Furthermore, FMD has potential neuroprotective properties against neurodegenerative diseases including stroke, Parkinson’s, and Alzheimer’s Disease, as it has proven efficacious in protecting the brain against aging and oxidative stress.
A recent human clinical study found that FMD had a significant effect on cardiovascular disease risk factors such as abdominal fat, inflammatory risk, total and LDL cholesterol and many others. Alongside beneficial implications in cardiovascular health, fasting has been shown to optimize health, increase longevity, promote weight loss, and enhance mental performance. Learn more about the science behind the Fasting Mimicking Diet, ongoing clinical research in the field, and the latest updates in Anti-Aging Medicine at Session 4: Fasting and the Future of Health (Day 1).
The 27th Annual Spring Congress offers attendees the unique opportunity to receive the most thoroughly comprehensive education in the latest developments within the Anti-Aging and Integrative Medicine industries. Two full days of interactive learning will be led by world-renowned keynote presenters, guaranteed to leave attendees with the most comprehensive, customized healthcare protocols to easily and effectively incorporate into their practice upon return.
You can still discover the power of what’s next, sign up today to gain access to our can’t miss event in Anti-Aging and Integrative Medicine.